Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
CURRENT ASSETS:
Cash and cash equivalents	$ 37,300	$ 182,055
Accounts receivable, net of allowance for doubtful accounts of $91,536 and $66,748 at December 31, 2019 and March 31, 2019, respectively	80,436	488,329
Inventory, net	1,560,048	1,533,792
Prepaid expenses and other current assets	83,240	262,208
Note receivable, net of unamortized discount of $884,958 and $0 at December 31, 2019 and March 31, 2019, respectively	1,365,042
Current assets from discontinued operations		1,000,387
TOTAL CURRENT ASSETS	3,126,066	3,466,771
Property and equipment, net	10,097,430	10,481,706
Intangible assets, net of accumulated amortization of $3,745 at December 31, 2019 and March 31, 2019	2,073,839	1,818,802
Note receivable, net of unamortized discount of $383,867 and $0 at December 31, 2019 and March 31, 2019, respectively	5,366,133
Deposits and other noncurrent assets	95,504	230,651
Operating lease right-of-use assets, net	144,146
Non-current assets from discontinued operations		14,025,372
TOTAL ASSETS	20,903,118	30,023,302
CURRENT LIABILITIES:
Accounts payable	1,998,994	1,374,771
Accrued interest	429,064	142,112
Accrued liabilities	469,053	244,931
Notes and convertible notes payable, net of unamortized discount of $1,008,086 and $799,410 at December 31, 2019 and March 31, 2019, respectively	4,860,221	2,229,812
Indebtedness to related parties	324,738
Note payable to related party	151,923
Income tax payable	506,145	506,145
Operating lease obligations, current	47,084
Finance lease obligations, current	134,239	80,132
Current liabilities from discontinued operations		2,134,277
TOTAL CURRENT LIABILITIES	8,921,461	6,712,180
Note payable, net of unamortized discount of $0 and $13,929 at December 31, 2019 and March 31, 2019, respectively		161,072
Operating lease obligations, long term	114,052
Finance lease obligations, long term	3,565,622	3,646,540
Long term liabilities from discontinued operations		2,347,511
TOTAL LIABILITIES	12,601,135	12,867,303
Commitments and contingencies (Note 8)
STOCKHOLDERS' EQUITY:
Common Stock, $0.0001 par value, 600,000,000 shares authorized, 270,553,352 and 240,627,102 shares issued and outstanding at December 31, 2019 and March 31, 2019, respectively	27,056	24,063
Additional paid-in capital	97,039,072	93,020,015
Accumulated deficit	(88,764,145)	(84,743,836)
TOTAL GB SCIENCES, INC. STOCKHOLDERS' EQUITY	8,301,983	8,300,242
Non-controlling interest in discontinued operations		8,855,757
TOTAL EQUITY	8,301,983	17,155,999
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 20,903,118	$ 30,023,302